Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Gemici A, Ozkalemkas F, Dogu MH, Tekinalp A, Alacacioglu I, Guney T, Ince I, Geduk A, Cagliyan GA, Maral S, Serin I, Gunduz E, Karakus V, Bekoz HS, Eren R, Pinar IE, Gunes AK, Sargın FD, Sevindik OG. Gemici A, et al. Among authors: serin i. Clin Lymphoma Myeloma Leuk. 2021 Aug;21(8):e686-e692. doi: 10.1016/j.clml.2021.04.004. Epub 2021 Apr 20. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34059487
Hemolytic anemia and plasma exchange.
Serin I, Dogu MH. Serin I, et al. Transfus Apher Sci. 2021 Oct;60(5):103245. doi: 10.1016/j.transci.2021.103245. Epub 2021 Aug 13. Transfus Apher Sci. 2021. PMID: 34412947
First-line Usage of Daratumumab, Lenalidomide, Dexamethasone (DRd) Combination in a Case of Castleman Disease Variant of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome (CD-POEMS).
Sevindik OG, Mutlu YG, Aydin BB, Serin I. Sevindik OG, et al. Among authors: serin i. Hemasphere. 2022 Jun 17;6(7):e728. doi: 10.1097/HS9.0000000000000728. eCollection 2022 Jul. Hemasphere. 2022. PMID: 35747589 Free PMC article. No abstract available.
To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission.
Sevindik OG, Mergen M, Mergen S, Mutlu YG, Aydın BB, Serin I. Sevindik OG, et al. Among authors: serin i. Ann Hematol. 2022 Nov;101(11):2545-2547. doi: 10.1007/s00277-022-04938-0. Epub 2022 Jul 29. Ann Hematol. 2022. PMID: 35906348 Free PMC article. No abstract available.
Gilteritinib (XOSPATA®) in Turkey: Early Access Program Results.
Dogu MH, Tekgunduz AIE, Deveci B, Korkmaz G, Comert M, Sevindik OG, Yokus O, Serin I. Dogu MH, et al. Among authors: serin i. Mediterr J Hematol Infect Dis. 2023 May 1;15(1):e2023031. doi: 10.4084/MJHID.2023.031. eCollection 2023. Mediterr J Hematol Infect Dis. 2023. PMID: 37180209 Free PMC article.
Intravascular B-cell lymphoma with generalized telangiectasias.
Erol VB, Mutlu YG, Balik B, Mert A, Mergen S, Mergen M, Serin I, Cakir A, Ozden F, Sevindik OG. Erol VB, et al. Among authors: serin i. J Dtsch Dermatol Ges. 2023 Sep;21(9):1025-1027. doi: 10.1111/ddg.15148. Epub 2023 Jul 3. J Dtsch Dermatol Ges. 2023. PMID: 37401140 No abstract available.
[Intravaskuläres B-Zell-Lymphom mit generalisierten Teleangiektasien].
Erol VB, Mutlu YG, Balik B, Mert A, Mergen S, Mergen M, Serin I, Cakir A, Ozden F, Sevindik OG. Erol VB, et al. Among authors: serin i. J Dtsch Dermatol Ges. 2023 Sep;21(9):1025-1028. doi: 10.1111/ddg.15148_g. J Dtsch Dermatol Ges. 2023. PMID: 37700402 German. No abstract available.
100 results